|
1
|
Gilead Sciences
Foster City,
California
|
$153M
|
–
|
–
|
–
|
|
|
2
|
Farallon Capital Management
San Francisco,
California
|
$41.8M
|
–
|
–
|
–
|
|
|
3
|
RA Capital Management
Boston,
Massachusetts
|
$34.7M
|
–
|
–
|
–
|
|
|
4
|
Commodore Capital
New York
|
$34M
|
–
|
–
|
–
|
|
|
5
|
Janus Henderson Group
London,
|
$28.5M
|
+$2.75M
|
+85,299
|
+11%
|
|
|
6
|
Paradigm Biocapital Advisors
New York
|
$22.6M
|
+$21.4M
|
+665,251
|
New
|
|
|
7
|
Point72 Asset Management
Stamford,
Connecticut
|
$20.4M
|
+$9.81M
|
+304,592
|
+103%
|
|
|
8
|
Vanguard Group
Malvern,
Pennsylvania
|
$19.5M
|
+$2.28M
|
+70,786
|
+14%
|
|
|
9
|
|
$10.8M
|
-$4.16M
|
-129,035
|
-29%
|
|
|
10
|
Parkman Healthcare Partners
Stamford,
Connecticut
|
$8.48M
|
-$52.3K
|
-1,624
|
-0.6%
|
|
|
11
|
Franklin Resources
San Mateo,
California
|
$7.16M
|
-$890K
|
-27,641
|
-12%
|
|
|
12
|
|
$6.54M
|
+$712K
|
+22,097
|
+13%
|
|
|
13
|
B Group Inc
Dallas,
Texas
|
$5.98M
|
–
|
–
|
–
|
|
|
14
|
Adage Capital Partners
Boston,
Massachusetts
|
$5.48M
|
+$5.19M
|
+161,000
|
New
|
|
|
15
|
Eversept Partners
New York
|
$5.43M
|
+$5.14M
|
+159,676
|
New
|
|
|
16
|
Stempoint Capital
New York
|
$5.33M
|
+$2.92M
|
+90,598
|
+137%
|
|
|
17
|
Geode Capital Management
Boston,
Massachusetts
|
$4.47M
|
+$39K
|
+1,212
|
+0.9%
|
|
|
18
|
Marshall Wace
London,
United Kingdom
|
$4.39M
|
+$1.41M
|
+43,860
|
+51%
|
|
|
19
|
Patient Square Capital
Menlo Park,
California
|
$4.32M
|
-$264K
|
-8,182
|
-6%
|
|
|
20
|
Caption Management
Oklahoma City,
Oklahoma
|
$3.63M
|
+$3.43M
|
+106,591
|
New
|
|
|
21
|
Millennium Management
New York
|
$3.34M
|
+$2.47M
|
+76,613
|
+355%
|
|
|
22
|
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
$2.73M
|
-$1.63M
|
-50,632
|
-39%
|
|
|
23
|
Seven Fleet Capital Management
Mountain View,
California
|
$2.51M
|
+$2.38M
|
+73,762
|
New
|
|
|
24
|
Superstring Capital Management
New York
|
$2.22M
|
+$2.1M
|
+65,273
|
New
|
|
|
25
|
Schonfeld Strategic Advisors
New York
|
$1.84M
|
-$2.18M
|
-67,653
|
-56%
|
|
